BRAT, Kristián, Michal SVOBODA, Jaromir ZATLOUKAL, Marek PLUTINSKÝ, Eva VOLAKOVA, Patrice POPELKOVA, Barbora NOVOTNA, Tomas DVORAK a Vladimir KOBLIZEK. Prognostic Properties of the GOLD 2023 Classification System. International Journal of chronic obstructive pulmonary disease. Albany: Dove Medical Press Ltd., 2023, roč. 18, April 2023, s. 661-667. ISSN 1178-2005. Dostupné z: https://dx.doi.org/10.2147/COPD.S410372.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Prognostic Properties of the GOLD 2023 Classification System
Autoři BRAT, Kristián (703 Slovensko, garant, domácí), Michal SVOBODA (203 Česká republika), Jaromir ZATLOUKAL (203 Česká republika), Marek PLUTINSKÝ (703 Slovensko, domácí), Eva VOLAKOVA (203 Česká republika), Patrice POPELKOVA (203 Česká republika), Barbora NOVOTNA (203 Česká republika), Tomas DVORAK (203 Česká republika) a Vladimir KOBLIZEK (203 Česká republika).
Vydání International Journal of chronic obstructive pulmonary disease, Albany, Dove Medical Press Ltd. 2023, 1178-2005.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30203 Respiratory systems
Stát vydavatele Nový Zéland
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 2.800 v roce 2022
Kód RIV RIV/00216224:14110/23:00130744
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.2147/COPD.S410372
UT WoS 000975875800001
Klíčová slova anglicky GOLD classification; COPD; mortality; prognosis
Štítky 14110215, rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Tereza Miškechová, učo 341652. Změněno: 20. 6. 2023 09:46.
Anotace
Introduction: Recently, the Global Initiative for Chronic Obstructive Lung Disease (GOLD) has published an update on the Global Strategy for Prevention, Diagnosis and Management of COPD, introducing a new classification of chronic obstructive pulmonary disease (COPD). Our aim was to assess the prognostic value of the new GOLD classification system in comparison with the previous GOLD classification systems (GOLD stages I-IV and GOLD groups A-D) and the BODE index.Methods: We used the data of 784 patients with COPD from the Czech Multicenter Research Database of COPD. Patient survival was analyzed with the use of Kaplan-Meier estimate and Cox model of proportional risks. ROC analysis and area under curve (AUC) were used for comparison of GOLD classifications and BODE index. The analyses were performed with the use of software R (version 4.2.0).Results: We analyzed data of 782 patients with complete data on GOLD classifications. The study population comprised 72.9% of men, 89.1% current or former smokers, with a mean age of 66.6 years, a mean BMI of 27.4 and a mean FEV1 44.9% of predicted. Probability of 5-year survival differed by GOLD classification. Application of the 2023 GOLD classification showed increased risk of death in group B (HR 1.82, 95% CI 1.14-2.92; p = 0.013) and in group E (HR 2.48, 95% CI 1.54-3.99; p<0.001). The ROC analysis showed that the overall prognostic value of the 2023 GOLD classification was similarly weak to previous A-D GOLD classification schemes (AUCs 0.557-0.576) and was lower compared to the GOLD 1-4 system (AUC 0.614) and even lower when compared to the BODE index (AUC 0.715).Conclusion: We concluded that the new GOLD classification system has poor prognostic properties and that specific prediction tools (eg, the BODE index) should be used for mortality risk assessment.
VytisknoutZobrazeno: 25. 4. 2024 14:13